With the new $94 million (€90 million) funding, the company will develop its pipeline of oral macrocycle drugs, nCycles, against validated biologic targets.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Lonza to Provide Tailored Offering for the Development of Oral Biologics Using Smart Capsules

By Feliza Mirasol

December 4th 2024

With its new offering, Lonza can tailor services to support smart capsule companies with its bi-layer capsule manufacturing technology.

Datwyler NeoFlex Plungers for large volume biologics | © Datwyler

Coated Plungers for Large Volume Biologics

By Pharmaceutical Technology Editors

December 1st 2024

Datwyler has launched new coated plungers in its NeoFlex line that are suitable for large volume biologics.

Circio and Certest to Collaborate on LNP Formulations

By Feliza Mirasol

November 21st 2024

The companies will collaborate to create and test circVec DNA–LNP formulations for use in potential therapeutic applications.

CordenPharma and Certest Team Up on Ionizable Lipids to Develop LNP Formulations

By Feliza Mirasol

June 12th 2024

CordenPharma has partnered with Spain-based Certest to develop ionizable lipids for LNP formulations.

...

About Us

Advertise

Editorial Info

Editorial Advisory Board

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777